Ingrid Arijs

Zaventem, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group.

Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group.

Journal: Journal of Crohn's & colitis

Published: August 09, 2026

Multi-stakeholder Delphi consensus on future care for inflammatory bowel disease in Belgium.

Multi-stakeholder Delphi consensus on future care for inflammatory bowel disease in Belgium.

Journal: Acta gastro-enterologica Belgica

Published: July 08, 2026

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Journal: Molecular oncology

Published: September 19, 2025

Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.

Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.

Journal: Nucleic acids research

Published: August 27, 2025

Effects of ALS-associated 5'tiRNAGly-GCC on the transcriptomic and proteomic profile of primary neurons in vitro.

Effects of ALS-associated 5'tiRNAGly-GCC on the transcriptomic and proteomic profile of primary neurons in vitro.

Journal: Experimental neurology

Published: November 11, 2024

Integrated analysis of transcriptomic and proteomic alterations in mouse models of ALS/FTD identify early metabolic adaptions with similarities to mitochondrial dysfunction disorders.

Integrated analysis of transcriptomic and proteomic alterations in mouse models of ALS/FTD identify early metabolic adaptions with similarities to mitochondrial dysfunction disorders.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: October 02, 2023

Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.

Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.

Journal: NPJ genomic medicine

Published: September 22, 2023

Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.

Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.

Journal: International journal of molecular sciences

Published: September 06, 2023

A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process.

A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process.

Journal: Journal of Crohn's & colitis

Published: July 13, 2023

PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma.

PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma.

Journal: Nature communications

Published: April 19, 2023

Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.

Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.

Journal: Journal of neuro-oncology

Published: April 18, 2023

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers.

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers.

Journal: British journal of cancer

Published: December 08, 2022

Showing 1-12 of 61

Last Updated: 09/26/2026